title: [Parenteral estrogen--a safe therapeutic alternative in prostatic cancer seen from the cardiovascular point of view?].
authors.affiliation: Medicinska kliniken, Södertälje sjukhus.
authors.forename: P
authors.initials: P
authors.lastname: Henriksson
authors.forename: R
authors.initials: R
authors.lastname: Stege
authors.forename: L
authors.initials: L
authors.lastname: Collste
authors.forename: A
authors.initials: A
authors.lastname: Pousette
authors.forename: B
authors.initials: B
authors.lastname: Von Schoultz
authors.forename: K
authors.initials: K
authors.lastname: Carlström
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D004958:Estradiol; C008958:polyestradiol phosphate
vernacular_title: Parenteralt östrogen--ett kardiovaskulärt säkert behandlingsalternativ vid prostatacancer?